Exhibitors at UBIFRANCE French Pavilion
Exhibitors at UBIFRANCE French Pavilion
Exhibitors at UBIFRANCE French Pavilion
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
ADOCIA<br />
115 avenue Lacassagne<br />
69003 LYON - FRANCE<br />
Phone: +33 4 72 610 610<br />
Fax: +33 4 72 36 39 67<br />
Email: o.soula@adocia.com<br />
Web site: www.adocia.com<br />
Contact: Olivier SOULA<br />
Adocia is a protein delivery company. Its proprietary innov<strong>at</strong>ive technology<br />
BioChaperone ® has been applied to growth factors for regener<strong>at</strong>ive medicine and<br />
to insulin and monoclonal antibodies for chronic diseases. Adocia has completed<br />
successfully a phase I for fast-acting human insulin and is currently evalu<strong>at</strong>ing a<br />
spray on 200 p<strong>at</strong>ients suffering from diabetic foot ulcer. Up to now Adocia has raised<br />
28M€ and is collabor<strong>at</strong>ing with 3 pharmaceutical companies.<br />
AEPODIA<br />
La Grande Arche - Paroi Nord<br />
92044 PARIS-LA DÉFENSE - FRANCE<br />
Phone: +33 1 40 90 30 14<br />
Email: info@aepodia.com<br />
Web site: www.aepodia.com<br />
Contact: Stéphanie ALVAREz LOUzAN<br />
Aepodia is experienced and specialized in Early Phase Clinical Development<br />
and Clinical Pharmacology studies. This strong pharmacological, scientific and<br />
study design background is a gre<strong>at</strong> asset to make well balanced (value/cost/time)<br />
recommend<strong>at</strong>ions regarding potential studies to be done in view of the new legisl<strong>at</strong>ion<br />
for health and nutrition claims. In collabor<strong>at</strong>ion with you, Aepodia provide ad hoc<br />
services like coordin<strong>at</strong>ion and monitoring of your study, st<strong>at</strong>istical support, prepar<strong>at</strong>ion<br />
and writing of clinical study protocols and lastly scientific reports and public<strong>at</strong>ions to<br />
support the claim or p<strong>at</strong>ent.<br />
24
Change language